Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Gastro Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Gastro Other
    Everolimus Is an Effective Treatment Option for Patients With Pancreatic Neuroendocrine Tumours: Presented at ESMO-GI - (DGDispatch)
    Proton Pump Inhibitors May Increase Risk for Clostridium difficile Outbreaks: Presented at ICC - (DGDispatch)
    Efficacy of Vaccination Against Traveller's Diarrhoea: Presented at ESPID - (DGDispatch)
    CT Colonography May Help High-Risk Patients Adhere to Follow-up Screening - (DGNews)
    Sevelamer Carbonate Approved in EU for Patients With Chronic Kidney Disease - (DGNews)

    News archive

     Recent webcasts/CME - Gastro Other
    • Biologics in Crohn's Disease: Treating Early, Treating Long-Term
    • Long-Term Sustainability Using Biologics in Crohn's Disease
    • Recent Updates in Crohn's Disease: Optimising Remission, Healing, and Quality of Life
    • Advances in the Management of Postoperative Ileus: Reducing the Clinical and Economic Burden
      Irritable Bowel Syndrome with Constipation (IBS-C): Improving Patient Care Assessment and Management

      Webcasts/CME archive

       Recent cases - Gastro Other
        An Unexpected Cause of Iron Deficiency Detected by Capsule Endoscopy
        Acute Abdominal Pain in a Patient Receiving Enoxaparin
        Splenic Rupture Following Colonoscopy, A Rare Complication
        Accurate Localization of Life Threatening Colonic Hemorrhage During Nuclear Medicine Bleeding Scan as an Aid to Selective Angiography
        Disabling Osteomalacia and Myopathy as the Only Presenting Features of Celiac Disease: A Case Report

        Cases archive
          




        my personal edition > gastro other > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        L-Arginine Application Speeds Healing of Anal Fissure: Presented at ASCRS

        By W. A. Thomasson
        Special to DG News

        CHICAGO, IL -- June 10, 2002 -- Topical application of a gel containing L-arginine 400 mg/mL promotes healing of chronic anal fissures, according to results of a small phase II study, presented Friday at the annual meeting of the American Society of Colon and Rectal Surgeons (ASCRS).

        The study was carried out and reported by M. Darby, MD, of University Hospital Dijkzigt in Rotterdam, Netherlands, and colleagues there and at Norgine Gmbh in Marburg, Germany.

        L-arginine is the natural precursor of nitric oxide (NO), the effects of which include relaxation of the anal sphincter. Topical application of artificial NO precursors, such as isosorbide dinitrate (ISDN), has been shown to promote fissure healing but is accompanied by frequent and sometimes severe headaches. The researchers hypothesized that because it is naturally present in the body, L-arginine might be free of headache risk.

        Fifteen patients (median age 36) were enrolled in the study. One patient dropped out of the study after a day, and one was excluded for protocol violation. The 13 evaluable patients had chronic anal fissures, and eight had previously been treated unsuccessfully with ISDN; five of the eight had experienced severe headache during ISDN treatment.
        Patients were treated with L-arginine gel for at least 12 weeks. Anal resting pressure decreased significantly after 12 weeks, from 89±17 to 74±14 mm Hg (p<0.005). There was likewise a significant increase in anodermal blood flow, from 0.36±0.25 to 0.64±0.33. Eight of the 13 fissures were healed and no patient had experienced headache after 12 weeks.

        These results indicate that topical application of L-arginine gel effectively promotes healing, even in patients who have not responded to other NO precursors. Furthermore, it does so without significant risk of headache. Precise details of efficacy and safety await larger studies, but these preliminary results are highly encouraging.



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send